- Advertise
- Contact Editorial
- Editorial Submission Guidelines
- Contact MJH Life Sciences
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Pharmaceutical Executive-08-01-2018
Pharmaceutical Executive
Emerging Biotech: Innovation, Location, and Inspiration
August 24, 2018
Features
38
8
Examining the rise and reach of biopharma in the key Northeast Corridor clusters of Boston, Philadelphia, and New Jersey.
Cross-Border Funding in the Life Sciences
August 21, 2018
Features
38
8
Record capital flows across global public and private markets has opened up new channels of investment in early-stage and novel science.
Face It. You’re Not a Biotech Anymore
August 09, 2018
Features
38
8
With increasing responsibilities and decision-making post-discovery, the traditional label of “biotech” is changing.
The Pulse of Biopharma M&A
August 08, 2018
Features
38
8
New trends report spotlights the promise and cautions for prospective life sciences dealmakers.
Congress, Feds, FDA Take Action in Opioid Crisis
August 07, 2018
Columns
38
8
Recent bipartisan efforts look to expand access for addiction treatment and stem inappropriate drug prescribing.
The Big Apple’s Fresh Start in Biotech
August 07, 2018
Features
38
8
Though challenges in space and affordability remain, New York City is emerging as a hotspot for biotech incubators, including one unique startup based in the city’s fast-growing innovation center, whose CEO, like many C-suite veterans, made the career leap from the big pharma world to forging new discoveries in medical science.
‘Emerging’ Product Launch Strategies
August 07, 2018
Features
38
8
Commercial leaders can boost product launches with a data-driven roadmap.
Biotech Investment: Reigning in Spain
August 06, 2018
Features
38
8
Over the last decade, Spain has seen a significant growth in venture-capital investment in the life sciences. We explore the driving forces.
Traditional Scientific Search is Broken
August 01, 2018
Columns
38
8
Using AI to revolutionize research inefficiency.
Tough Fight Looms in Preserving R&D Incentives
August 01, 2018
Columns
38
8
European drug innovators ready their defense as the Commission mulls manufacturing waiver for generic competitors.
From Science to Success
August 01, 2018
From the Editor
38
8
A common takeaway in our exploration of "Emerging Biopharma" appears to be that these companies are those that go beyond pure discovery-and put equal efforts into the pivot to potential commercialization.
Country Report: Portugal
August 01, 2018
Special Sponsored Section
38
8
Behind an economic revival in Portugal, including healthcare spending growth, the nation’s life sciences sector is benefiting as well, with Portugal diverging from the European averages to show an increase in R&D and innovation.
Pharmaceutical Executive, August 2018 Issue (PDF)
August 01, 2018
Issue PDF
38
8
Click the title above to open the Pharmaceutical Executive August 2018 issue in an interactive PDF format.